The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their...
SARS-CoV-2
National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or “nanobodies,” against SARS-CoV-2 that were produced...
Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent...
NIAID-Led Study of mRNA Vaccine Supports Advance to Phase 3 Human Trials Two doses of an experimental vaccine to prevent...
In a Perspective for the New England Journal of Medicine(link is external), members of the National Institutes of Health’s Accelerating COVID-19 Therapeutic...
At a Glance Early data showed that off-label use of a cancer drug reduced respiratory distress and over-reactive immune responses...
A single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six rhesus macaques from pneumonia caused by...
